Search research articles
Contact Us
Filters
Showing results (151-160 of 166) with videos related to
Page
of 17
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 31, 2024
Stone at the same location for 2 months predicts impacted stones and stone-free status after shock wave lithotripsy for ureteral stones: A Funabashi clinic expert study
Kazuyoshi Nozumi, Shinichi Sakamoto, Xue Zhao, et al.
Anticancer Research
|
November 29, 2023
Preoperative PI-RADS v2.1 Scoring System Improves Risk Classification in Patients Undergoing Radical Prostatectomy
Yudai Fukui, Yasutaka Yamada, Shinichi Sakamoto, et al.
Anticancer Research
|
February 2, 2024
Copy Number Gain in Androgen Receptors Predicts the Poor Prognosis in Japanese Castration-resistant Prostate Cancer
Shinichi Sakamoto, Keisuke Ando, Sangjon Pae, et al.
Cancer Research Communications
|
July 2, 2024
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, et al.
Molecular Cancer Therapeutics
|
July 31, 2020
Tipifarnib as a Precision Therapy for <i>HRAS</i>-Mutant Head and Neck Squamous Cell Carcinomas
Mara Gilardi, Zhiyong Wang, Marco Proietto, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 28, 2024
Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism
Xingyu Wu, Sendi Rafael Adame-Garcia, Keiichi Koshizuka, et al.
Cancer Science
|
January 8, 2024
L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity
Junryo Rii, Shinichi Sakamoto, Atsushi Mizokami, et al.
The Prostate
|
February 27, 2024
Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix
Shuhei Kamada, Shinichi Sakamoto, Ryo Kinoshita, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 2, 2023
Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era
Yusuke Goto, Takanobu Utsumi, Masafumi Maruo, et al.
Ecology and Evolution
|
May 7, 2025
Epigenetic Clock in Bears: A Simple Cost-Effective Blood DNA Methylation-Based Age Estimation Method Applicable to Multiple Bear Species
Michito Shimozuru, Shiori Nakamura, Jumpei Yamazaki, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 166) with videos related to
Sort By:
Page
of 17
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 31, 2024
Stone at the same location for 2 months predicts impacted stones and stone-free status after shock wave lithotripsy for ureteral stones: A Funabashi clinic expert study
Kazuyoshi Nozumi, Shinichi Sakamoto, Xue Zhao, et al.
Anticancer Research
|
November 29, 2023
Preoperative PI-RADS v2.1 Scoring System Improves Risk Classification in Patients Undergoing Radical Prostatectomy
Yudai Fukui, Yasutaka Yamada, Shinichi Sakamoto, et al.
Anticancer Research
|
February 2, 2024
Copy Number Gain in Androgen Receptors Predicts the Poor Prognosis in Japanese Castration-resistant Prostate Cancer
Shinichi Sakamoto, Keisuke Ando, Sangjon Pae, et al.
Cancer Research Communications
|
July 2, 2024
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, et al.
Molecular Cancer Therapeutics
|
July 31, 2020
Tipifarnib as a Precision Therapy for <i>HRAS</i>-Mutant Head and Neck Squamous Cell Carcinomas
Mara Gilardi, Zhiyong Wang, Marco Proietto, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 28, 2024
Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism
Xingyu Wu, Sendi Rafael Adame-Garcia, Keiichi Koshizuka, et al.
Cancer Science
|
January 8, 2024
L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity
Junryo Rii, Shinichi Sakamoto, Atsushi Mizokami, et al.
The Prostate
|
February 27, 2024
Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix
Shuhei Kamada, Shinichi Sakamoto, Ryo Kinoshita, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 2, 2023
Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era
Yusuke Goto, Takanobu Utsumi, Masafumi Maruo, et al.
Ecology and Evolution
|
May 7, 2025
Epigenetic Clock in Bears: A Simple Cost-Effective Blood DNA Methylation-Based Age Estimation Method Applicable to Multiple Bear Species
Michito Shimozuru, Shiori Nakamura, Jumpei Yamazaki, et al.
Page
of 17